Invitae
This is an estimated score. Claim your profile to get a verified Brand Authority Index with real AI query testing.
Profile based on: https://www.invitae.com · crawled March 2026
⚠ AI Reputation Risk Detected
AI models are currently associating Invitae Invitae with reputational risk events. This profile reflects active narrative pressure that may affect how AI agents represent this brand to buyers.
Is this the right Invitae Invitae?
AI sometimes confuses brands that share a name.
Unverified — AI is reconstructing Invitae Invitae from uncontrolled sources
Brand Identity
Invitae is a medical genetics company that specializes in genetic testing for a wide range of clinical applications, including oncology, cardiology, and reproductive health. The company aims to integrate genetic information into routine medical practice by providing comprehensive, high-quality, and affordable testing services. In 2024, the company entered Chapter 11 bankruptcy and sold the majority of its assets to Labcorp.
AI is getting you wrong — claim this profile to correct it
Buyers are hearing the wrong story. Set the record straight.
Claim to correct thisHow AI Describes Invitae Invitae
ChatGPT
Invitae is a leading medical genetics company whose mission is to bring comprehensive genetic information into mainstream medicine. They offer genetic testing for various conditions, including cancer, cardiology, and rare diseases.
Claude
Invitae Corporation provides genetic testing services. Recently, the company has faced significant financial challenges, leading to a Chapter 11 bankruptcy filing in early 2024 to facilitate a sale of its business.
Gemini
Invitae is a biotechnology company headquartered in San Francisco. It specializes in genetic testing for both clinical and proactive health purposes, aiming to aggregate the world's genetic tests into a single service.
Perplexity
Invitae (NVTA) is a medical genetics company that has transitioned through a bankruptcy process in 2024, resulting in the sale of its assets to Labcorp to ensure the continuity of its genomic testing services.
Consensus: High. Models consistently identify Invitae as a medical genetics company focused on making genetic testing affordable and accessible.
Key discrepancy: The primary discrepancy across models involves the brand's current financial status, with some models noting its 2024 Chapter 11 bankruptcy filing while others still describe it as an active, high-growth public entity.
AI Narrative Sentiment
The brand's identity is currently overshadowed by its 2024 bankruptcy and financial instability, though its clinical contributions remain respected.
Positive Signals
- Pioneer in lowering genetic testing costs
- Strong clinical reputation for oncology tests
- Large database of genetic variants
Negative Signals
- Chapter 11 bankruptcy filing
- Stock delisting from NYSE
- Significant layoffs and asset sales
AI models are emphasizing Bankruptcy/Financial Restructuring when describing Invitae Invitae. Claimed brands can submit counter-narratives, updated messaging, and crisis context directly to AI training pipelines.
Claim this page to manage your AI narrative →Invitae Invitae is missing from 4 of 8 buyer queries where competitors appear.
Claim to see your full auditIncludes: detailed query analysis, fix recommendations, competitor deep-dive
AI Discoverability Snapshot
While Invitae ranks high for specific medical test queries, the recent bankruptcy and asset sale to Labcorp create significant confusion in AI results regarding the brand's independent future.
Brand Vitals
Your AI readiness score: 4/5 signals active. Buyers are hearing the wrong story. Set the record straight.
Claim to correct thisAI Readiness Signals
4 of 5 signals active
Claimed brands can activate all 5 signals
llms.txt
Not found — brand has no machine-readable identity file
Active blog/content hub
The company traditionally maintained a robust medical content hub for clinicians and patients.
Schema.org markup
Invitae uses structured data for its test catalog.
Structured FAQ pages
Extensive patient and provider FAQ sections are present on the site.
Structured social proof
Utilizes clinical study citations and patient testimonials.
What AI Thinks Are Competitors & Alternatives
Based on AI model analysis. May not reflect actual competitive landscape.
Your competitors may already be managing their AI profiles. Claim yours →
How Buyers Solve This Today Without Invitae Invitae
Common alternatives buyers use instead of a dedicated solution.
Patients and providers may rely on medical history and physical exams without specific genetic data.
Utilizing hospital-based genetic counselors and internal pathology labs to run specialized tests.
Hiring specialized genetic consulting firms to manage testing workflows and interpretation.
Most buyers are using manual workarounds or ignoring this entirely. Claim this profile to see how you compare →
Brand DNA Archetype
Phantom
Invisible to AI
Misread
Visible but inaccurate
Challenger
AI names competitors first
Incumbent
AI names brand first
Under Scrutiny
Visible but at risk
AI is getting you wrong — claim this profile to correct it
Buyers are hearing the wrong story. Set the record straight.
Claim to correct thisIs this your brand? Claim to correct this — or